Option chain shows key data for Altamira Therapeutics's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Altamira Therapeutics.

Altamira Therapeutics (OTC:CYTOF) Stock, Option Chain

Altamira Therapeutics Ltd is dedicated to developing therapeutics that address unmet medical needs. It is active in RNA therapeutics, allergy and viral infections, and inner ear disorders. Its product Bentrio is a drug-free nasal spray for personal protection against airborne viruses and allergens. The company's OligoPhore / SemaPhore platform is a versatile system that allows the complexation of therapeutic RNAs with a proprietary peptide to form a nanoparticle formulation. This formulation allows to deliver of therapeutic RNA by systemic administration to tissues affected by leaky vasculature, a hallmark of solid tumors and certain inflammatory conditions.

ALTAMIRA THERAPEUTICS LTD by Altamira Therapeutics Ltd.

Altamira Therapeutics Ltd

Press Releases

Altamira Therapeutics Announces Transition from NASDAQ to OTC Markets

Altamira Therapeutics Announces Successful Nanoparticle-Based Delivery of Circular RNA

Altamira Therapeutics Announces Collaboration on Radiopharmaceutical Targeting Strategies

Altamira Announces Notice of Allowance from USPTO for Bentrio Nasal Spray Patent

Altamira Therapeutics to Host Full Year 2024 Financial Results and Business Update Call on April 30, 2025

Altamira Therapeutics Provides Business Update, Reports Full Year 2024 Financial Results

CYTO

CYTOF

Altamira Therapeutics

Comments

Altamira Therapeutics

Altamira Therapeutics (CYTOF) Options

No option chain data available. Please try again later

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell